)

Herantis Pharma (HRNTS) investor relations material
Herantis Pharma Study Result summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Study background and objectives
HER-096 is a subcutaneously administered mimic of CDNF, aiming to be the first disease-modifying and neurorestorative treatment for Parkinson's disease.
The phase 1b trial evaluated HER-096 in Parkinson's disease patients, focusing on safety, tolerability, and pharmacokinetics, following promising preclinical and phase I-A data.
The study included elderly healthy volunteers (part one) and early-stage Parkinson's patients (part two).
Inclusion criteria ensured early idiopathic Parkinson's with confirmed dopaminergic deficit and stable medication.
The study was conducted at two sites in Finland, funded by The Michael J. Fox Foundation and Parkinson's UK, and completed within timeline and budget.
Study design and patient characteristics
Part one: single 300 mg dose in elderly healthy volunteers to assess safety and PK.
Part two: 24 Parkinson's patients randomized to 200 mg or 300 mg HER-096 or placebo, two injections per week for four weeks.
Cohorts balanced in age, sex, BMI, disease stage, and medication use.
Disease duration and symptom severity were similar across groups.
All patients used 1–3 symptomatic medications; beta blockers were used for tremor control in some cases.
Safety and tolerability results
No serious adverse events related to HER-096; one unrelated SAE occurred in placebo.
Most adverse events were mild, transient injection site reactions; systemic AEs were rare.
No clinically significant lab, MRI, or hematology abnormalities observed.
No evidence of antidrug antibody formation in HER-096 recipients.
All participants completed the study without disruptions.
Next Herantis Pharma earnings date

Next Herantis Pharma earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage